Showing results (871-880 of 7,009) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Non-small-cell lung cancer: multimodality approach in stage-III resectable diseaseMichael Thomas, Petra Hoffknecht, Cornelia Droege, et al.Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?Patrick Micke, Arne OstmanLung Cancer (Amsterdam, Netherlands)|November 24, 2004
Interventional endoscopic treatmentLutz FreitagLung Cancer (Amsterdam, Netherlands)|February 9, 2005
Development of docetaxel in advanced non-small-cell lung cancerChandra P Belani, John EckardtLung Cancer (Amsterdam, Netherlands)|February 17, 2005
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar featuresMustafa Erman, Dominique Grunenwald, Frederique Penault-Llorca, et al.Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Prognostic value of smoking status in operated non-small cell lung cancerPeyman Sardari Nia, Joost Weyler, Cecile Colpaert, et al.Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literatureNaveed Alam, Frances A Shepherd, Timothy Winton, et al.Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC)A Vergnenègre, C Daniel, H Léna, et al.Lung Cancer (Amsterdam, Netherlands)|January 24, 2004
Environmental tobacco smoke exposure in women with lung cancerM de Andrade, J O Ebbert, J A Wampfler, et al.Lung Cancer (Amsterdam, Netherlands)|January 24, 2004
Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancerPaolo Bidoli, Simonetta C Stani, Luigi Mariani, et al.Pageof 701